Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)

Clinical trial NCT00234065 · COMPLETED

Trial details

NCT number: NCT00234065
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cerebral Infarction

Start date: 2003-12-01
Primary completion: 2008-12-01
Enrollment: 2800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.